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Association with inflammatory cells and 
apolipoproteins to the progression of atherosclerosis
Hyun-Seon Eo, Kyung-Bok Lee, Ae-Kyeong Kim, Min-Hee Kim, Do-Hyung Kim, Dong-Ik Kim
Division of Vascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Purpose:  Inflammatory cells are known to be associated with the progression of atherosclerosis and plaque rupture. 
However, the relation to inflammatory cells and apolipoproteins on the progression of atherosclerosis is unknown. This 
study was aimed at examining the different expressions of inflammatory cells and evaluate the effect of apolipoprotein 
(APO) C1 and APO E during the progression of atherosclerosis. Methods: Ten atherosclerotic tissues were compared with 
five non-atherosclerotic tissues. The presence of vascular smooth muscle cells (VSMCs), macrophages, T-cells, APO C1, and 
APO E were identified by Western blotting and immunohistochemical analysis with antibodies. The senescence was ana-
lyzed by senescence-associated β-galactosidase. Results: The protein expression and senescence of macrophages, APO C1 
and APO E were significantly higher in the main atherosclerotic lesion than the non-atherosclerotic lesion. A high concen-
tration of inflammatory cells and the paucity of VSMCs were present in the shoulder area. In addition, macrophage and 
T-cells are expressed in the early stage of atherosclerotic development and more expanded in advanced atherosclerotic 
plaques. APO C1 was expressed mainly within the necrotic core, and APO E existed mostly around the necrotic core and the 
fibrous cap in advanced atherosclerotic plaques. Conclusion: Our study indicated that the expression and the senescence of 
macrophage and T-cells may be closelyrelated to induction and deposition of APO C1 and APO E. This contributes to the de-
velopment and progression of atherosclerotic plaque by expanding the necrotic core.
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INTRODUCTION
Atherosclerosis is understood recently to be an in-
flammatory process that involves the infiltration of in-
flammatory cells and complex structures that consists of 
smooth muscle cells, macrophages, lymphocytes, micro-
vessels and different types of collagen [1-4]. It is known 
that the major cell types of inflammatory cells are macro-
phages and T-lymphocytes which are closely associated 
with plaque rupture [5]. In addition, vascular smooth 
muscle cells (VSMCs) proliferation has been identified in 
early atherosclerotic lesions. This is in contrast to the low 
level proliferation of VSMCs detected in advanced lesions, 
which suggests that the VSMCs might be senescent, as 
demonstrated by the senescence-associated β-galactosid-
ase (SAβG) activity [1,2,6].
As the atherosclerosis progresses, the VSMCs become a 
senescent and undergo the apoptosis [7,8]. The apoptotic Hyun-Seon Eo, et al.
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cells were found in areas near or within the lipid rich core, 
and the apoptosis of VSMCs is associated with the remod-
eling and stability of atherosclerotic plaque [9,10]. In crit-
ical regions of the plaque, the apoptosis of VSMCs predis-
poses the plaque to rupture and subsequent thrombosis 
[11].
The interaction between apoptotic VSMCs and in-
flammatory cells, such as macrophages and T-lympho-
cytes, leads to the thinning of the fibrous cap overlying the 
lipid-rich core and this contributes to plaque rupture. It 
has been known that apolipoprotein (APO) C1 and APO E 
are expressed in macrophages and most of the expressed 
genes induced by macrophage colony-stimulating factor 
were identified to be APO C1 and APO E [12,13]. Further, 
the expression of APO C1 is highly correlated with an APO 
E expression [12]. The expressed macrophage and T-cells 
may affect the degradation of the extracellular matrix and 
the depletion of VSMCs, which are both seen in the devel-
opment of atherosclerosis. We have previously reported 
that APO C1 and APO E were prominently expressed in 
carotid atherosclerotic lesions, as compared to non-athe-
rosclerotic arteries [14].
In the present study, we compared the regional differ-
ences of the expressions and senescence of cellular compo-
nents, such as VSMCs, cluster of differentiation 68 (CD68, 
macrophage), CD3 (T-lymphocyte), APO CI, and APO E, 
in atherosclerotic lesions. In addition, we identified that 
the expression of cellular components in less advanced 
atherosclerotic plaques by comparing more advanced 
atherosclerotic plaques.
METHODS
Specimens
A total of 10 atherosclerotic tissues were obtained 
(arteries from carotid endarterectomy) and compared 
with five non-atherosclerotic tissues as a control group 
(arteries from brain death donors). The tissue specimens 
were immediately frozen and stored at -70
oC in liquid 
nitrogen. This study was approved by the Institutional 
Review Board at our institution and written informed con-
sent was obtained from the patients to use their tissues. 
The Investigation conforms with the principles outlined in 
the Declaration of Helsinki.
Western blot analysis
Fifty μg protein from each specimen was used for the 
analyses of human telomerase reverse transcriptase 
(hTERT, diluted 1:1,000; Santa Cruz Biotechnology, Santa 
Cruz, CA, USA), CD68, SM-α actin, APO C1, APO E, and 
actin by performing Sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis on 8% to 15% gels. The pro-
tein samples were then incubated with polyclonal rabbit 
anti-human hTERT, monoclonal mouse anti-human CD68 
(diluted 1:100; Dako, Glostrup, Denmark), monoclonal 
mouse anti-human α-smooth muscle actin (SM-α actin, di-
luted 1:400; Dako), polyclonal rabbit anti-human apolipo-
protein C1 (diluted 1:200; Chmi-con, Rosemont, IL, USA), 
polyclonal rabbit anti-human apolipoprotein E (diluted 
1:500; Dako) and polyclonal goat anti-human actin (diluted 
1:200; Santa Cruz Biotechnology) as primary antibodies 
for 1 hour and next they were incubated with polyclonal 
goat anti-rabbit immunoglobulin/horseradish peroxidase 
(HRP) (diluted 1:2,000; Dako), polyclonal rabbit anti-goat 
immunoglobulin/HRP (diluted 1:2,000; Dako) and mono-
clonal goat anti-mouse immunoglobulin/HRP (diluted 
1:2,000; Becton, Dickinson and Company, Franklin Lakes, 
NJ, USA) as secondary antibodies during 1 hour. Following 
that, the specimens were transferred onto hybond en-
hanced chemiluminescence reagents (ECL; Amersham 
Canada, Oakville, ON, Canada) nitrocellulose membranes 
(Schleicher and Schuell, Keene, NH, USA) and these were 
finally developed with the use of ECL.
SAβG staining
The SAβG activity was determined by using a SAβG 
staining kit from Cell Signaling Technology (Beverly, MA, 
USA). The tissues were washed twice in phosphate-buf-
fered saline (PBS), fixed for 15 minutes at room temper-
ature in fixative solution (2% formaldehyde, 0.2% gluta-
raldehyde), washed twice in PBS, and next incubated for 
24 hours at 37
oC in SAβG staining solution (pH 6.0) that 
contained 1 mg/mL 5-bromo-4-chrolo-3-indlyl β-D-gal-
actopylanoside, 5 mmol/L potassium ferrocyanide, 5 
mmol/L potassium fericyanide, 150 mmol/L NaCl, 2 Inflammatory cells and apolipoproteins
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Fig. 1. Expressions of cluster of differentiation 68 (CD68), human telomerase reverse transcriptase (hTERT), apolipoprotein C1 (APO C1), and 
APO E in various lesions of atherosclerotic and non-atherosclerotic arteries. (A) Western blot analysis for the CD68, hTERT, APO C1, and APO
E in non-atherosclerotic iliac arteries (lanes 1, 2), non-atherosclerotic carotid arteries (lanes 3, 4), the main lesion of the atheromas (lanes 5, 6),
and the area adjacent to the atheromas (lane 7). Western blot results were the same for experiment five. (B) Specimens of carotid 
endarterectomy: ⓐ  the main lesion of carotid atheroma and ⓑ  the area adjacent to the atheroma.
mmol/L MgCl2, 0.01% sodium deoxycholate and 0.02% 
Nonidet-40. The 10 μm-thick formalin-fixed, paraf-
fin-embedded sections were then subjected to immuno-
histochemistry.
Immunohistochemistry
After deparaffinization followed by dehydration, the 
serial paraformaldehyde-fixed paraffin sections were 
rinsed 3 times for 5 minutes each time in PBS. The paraf-
fin-embedded tissues were blocked with using Dako 
Cytomation peroxidase blocking reagent buffer for 30 
minutes. The slides were covered with goat serum for 1 
hour and then incubated with the following antibodies: 
monoclonal mouse anti-human α-smooth muscle actin 
(diluted 1:50; Dako), monoclonal mouse anti-human 
CD68 (diluted 1:100; Dako) and, polyclonal rabbit anti-hu-
man CD3 (diluted 1:50; Dako) for 1 hour at room temper-
ature, and then, the slides were washed for 3 times for 5 
minutes each time in PBS. The slides were then exposed to 
envision buffer for 30 minutes and this was followed by 
treatment with diaminobenzidine for 30 minutes. Finally 
the slides were dehydrated in ethanol and xylene.
RESULTS
Expression of inflammatory cells and apolipopro-
teins in the main and adjacent lesions of athero-
sclerotic plaques
The expressions of CD68, hTERT, APO C1 and APO E 
were prominent in the carotid atheromas (lanes 5 & 6 in 
Fig. 1A) compared with the non-atherosclerotic iliac (lanes 
1 & 2 in Fig. 1A) arteries and non-atherosclerotic carotid 
(lanes 3 & 4 in Fig. 1A) arteries.
 In the main lesion of the atheroma (lanes 5 & 6 in Fig. 1A 
and ⓐ  lesion in Fig. 1B), CD68, hTERT, APO C1 and APO 
E were more prominently expressed than the adjacent area 
(lane 7 in Fig. 1A and ⓑ  lesion in Fig. 1B). 
Cellular senescence and inflammatory cells in the 
shoulder area of atherosclerotic plaques
β-galactosidase (β-gal) activity, which is known as a sen-
escence marker of atherosclerosis, was represented in the 
carotid atherosclerotic plaque (green area in Fig. 2A-2) but 
not in the non-atherosclerotic artery (Fig. 2A-1). In addi-
tion, VSMCs, macrophages and T-lymphocytes were ex-
pressed in the media of the β-gal stained areas (Fig. 2B-3-1, 
4-1, and 5-1). The shoulder lesions, indicated as boxes in 
Fig. 2B-3-1, 4-1, and 5-1, had a small number of VSMCs as Hyun-Seon Eo, et al.
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Fig. 2. β-galactosidase (β-gal) acti-
vity in various arterial specimens 
(A) and β-gal and inmmunohisto-
chemical staining in atherosclerotic 
plaques (B). (A) Photographs of the 
various arteries stained for β-gal 
activity (non-atherosclerotic iliac 
artery (1); endarterectomized caro-
tid atheroma (2)). (B) The serial 
sections of the luminal layer of 
endarterectomized carotid atheroma 
stained for β-gal activity and im-
munohistochemistry stains for α- 
smooth muscle actin (3), CD3 (4), 
and CD68 (5). The (3), (4), and (5) 
were doble stained with β-gal and 
each antibody. The results were the 
same for experiment five (Magnifi-
cation: ×40 for (3), (4), and (5); ×200
for (3-1), (4-1), and (5-1)).Inflammatory cells and apolipoproteins
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Fig. 3. Immunohistochemistry for 
α-smooth muscle actin of vascular 
smooth muscle cells, cluster of 
differentiation 68 (CD68) of 
macrophages, CD3 of T-lymph-
ocytes, apolipoprotein C1 (APO 
C1), and APO E in non- 
atherosclerotic arteries, ‘focal’
atherosclerotic plaques, and ‘dif-
fuse’ atherosclerotic plaques in 
endarterectomized carotid athe-
roma. Arrows indicate the shoul-
der lesion of the atheromas. The 
results were the same for experi-
ment five (Magnification, ×12.5).
VSMC, vascular smooth muscle 
cell.
compared with the number of macrophages and 
T-lymphocytes. The expression of T-lymphocytes was 
more prominent in the β-gal stained area, as compared 
with the non-stained area (Fig. 2B-4, 4-1). 
Expression of inflammatory cells and apolipopro-
teins in the ‘focal’ and ‘diffuse’ atherosclerotic pla-
ques
The sites of critical stenosis were retrieved from the en-
darterectomy specimens. Atherosclerotic plaques in crit-
ical stenosis were divided into ‘focal’ and ‘diffuse’ athero-Hyun-Seon Eo, et al.
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sclerotic plaques according to the morphological features. 
The focal atherosclerotic plaques showed small pools of 
extracellular lipid and hyperplasia of the VSMCs and dif-
fuse atherosclerotic plaques demonstrated a rich necrotic 
core and/or a core of extracellular lipid, including choles-
terol crystals. The diffuse atherosclerotic plaques were 
considered to be a more advanced atherosclerotic lesion 
than the focal plaques because these had a larger area of 
the plaque and a more prominent expression of in-
flammatory cells and only the rare expression of the 
VSMCs (Fig. 3). The histological examination revealed 
that the number of VSMCs was higher in the focal athero-
sclerotic plaques than that in the non-atherosclerotic ar-
tery (Fig. 3). Macrophages and T-lymphocytes expressed 
in the focal and diffuse atherosclerotic lesions, but not in 
the non-atherosclerotic arteries. In addition, the ex-
pression of inflammatory cells was more prominent in the 
shoulder area of the focal lesions (arrow in Fig. 3). The ex-
pressions of APO C1 and APO E were showed in the focal 
and the diffuse lesions, but not in the non-atherosclerotic 
arteries (Fig. 3). In the diffuse lesion, macrophages were 
prominently expressed in the fibrous cap. Moreover, APO 
E was mainly represented in the regions around the ne-
crotic core and fibrous cap, and APO C1 was mainly dem-
onstrated within the necrotic core.
DISCUSSION
The development of atherosclerosis is induced by the 
migration, proliferation and differentiation of inflam-
matory cells, mainly macrophages and T-lymphocytes. 
The monocytes differentiate into macrophages in the ves-
sel wall and the macrophages produce various proteases 
that degrade the extracellular matrix [15]. Our study 
found that there was a high expression of macrophages in 
the main lesion of atherosclerotic plaques as compared 
with that of the area adjacent to the main lesion, as was as-
sessed by Western blot analysis (Fig. 1A). Macrophages ex-
press APO E, which has an anti-proliferative effect on 
VSMCs [16]. APO E null mice have been extensively used 
as an animal model for atherosclerosis as these mice devel-
op atherosclerosis that is similar to that found in human 
[17,18]. In addition, it has been previously reported that 
hTERT-APO E doubly deficient mice show impaired pro-
liferation of both lymphocytes and macrophages, and re-
duced atherosclerosis [19]. However, we found that APO E 
and hTERT were more highly expressed in atherosclerotic 
lesions than in non-atherosclerotic arteries (Fig. 1A). This 
finding suggested that the expressions of APO E and 
hTERT in atherosclerotic plaque may be affected by the 
proliferation of macrophages during the development of 
atherosclerosis. Also, we suppose that the difference of ex-
pression for these proteins in a same atherosclerotic pa-
tient may be the important causes to the presence of athe-
rosclerotic lesion.
The expression of APO C1 is highly correlated with the 
APO E expression, and this is probably the result of their 
close location in the APO E/C1/C4/C2 gene cluster [8]. We 
found that APO C1 and APO E were overexpressed in 
atherosclerotic lesions, as compared with that of non-athe-
rosclerotic arteries, by performing Western blot analysis 
(Fig. 1A). 
Foam cells of a macrophage origin, as indicated by im-
munoreactivity for CD-68, kill the adjacent VSMCs in the 
atherosclerotic plaque and the rupture sites are also char-
acterized by the paucity of VSMCs and the high concen-
tration of macrophages and inflammatory cells [20-22]. 
Our histologic examinations indicated that there were 
high concentrations of macrophages and T-lymphocytes 
and the loss of VSMCs in the shoulder area and this area is 
known to be prone to plaque rupture [9]. This study, we 
showed that the loss of VSMCs and the prominent ex-
pression of macrophages during the progression of athe-
rosclerosis (Fig. 3). 
β-gal staining is a useful marker for cellular senescence 
in both in vitro and in vivo because β-galactosidase is a met-
abolic enzyme that is highly expressed in senescent cells. 
But, there is still a need to identify whether the cells show-
ing  β-gal staining are genuine senescent cells because 
β-gal positive cells may be macrophages with a high lyso-
somal content. Interestingly, our study demonstrated that 
most of the areas showing β-gal staining exactly over-
lapped with the areas that expressed T-lymphocytes in 
atherosclerotic plaques, as compared with macrophages 
and VSMCs. Therefore, β-gal staining in cells is possibly Inflammatory cells and apolipoproteins
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not due to a high lysosomal content, but rather, this is due 
to cellular senescence. It indicates that the T-lymphocytes 
may be a crucial feature in atherosclerosis and it is also 
closely associated with the progression of atherosclerosis. 
Macrophages and T-lymphocytes are known to be ma-
jor cell types that found at sites of rupture [7] and, in the 
present study, the senescence of these cells and the lack of 
VSMCs were observed in the shoulder area of athero-
sclerotic plaques (Fig. 2). Our findings showed that large 
lipid-rich necrotic core were present in the ‘diffuse’ athe-
rosclerotic lesions and this is resulted of increased apopto-
sis and decreased scavenging, which characterizes more 
advanced atherosclerotic plaque. APO C1 and APO E were 
highly expressed in the ‘focal’ and ‘diffuse’ atherosclerotic 
plaques, as compared with that in the non-atherosclerotic 
arteries. In particular, macrophages were prominently in 
the fibrous cap, APO C1 was mainly expressed within the 
necrotic core and APO E was particularly expressed 
around the necrotic core and fibrous cap in more advanced 
atherosclerotic plaques (Fig. 3). These findings suggest 
that APO C1 and APO E are strongly associated with the 
expansion of necrotic core during the progression of 
atherosclerosis.
In conclusion, our findings represent that expression 
and senescence of macrophage and T-cells involved in the 
progression of atherosclerosis and suggest that expression 
and deposition of APO C1 and APO E contributes to the 
destabilization of atherosclerotic plaque by expanding the 
necrotic core. Therefore, the inhibition of macrophage, 
T-cells, the APO C1 and APO E may well become an in-
creasingly important therapeutic strategy for preventing 
the progression of atherosclerosis.
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